ChemicalBook >> CAS DataBase List >>Ramucirumab
Ramucirumab
- CAS No.
- 947687-13-0
- Chemical Name:
- Ramucirumab
- Synonyms
- Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
- CBNumber:
- CB72738188
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD01092518
- MOL File:
- Mol file
Last updated:2024-07-02 08:55:16
storage temp. | Store at -20°C |
---|---|
solubility | Soluble in DMSO |
form | Liquid |
color | Colorless to light yellow |
FDA UNII | D99YVK4L0X |
NCI Dictionary of Cancer Terms | ramucirumab |
NCI Drug Dictionary | ramucirumab |
ATC code | L01XC21 |
Ramucirumab price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-0031056 | Ramucirumab | 947687-13-0 | 1mg | $400 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 1mg | $425 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | ATB0023429 | RAMUCIRUMAB 95.00% | 947687-13-0 | 5MG | $498.75 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 2mg | $650 | 2021-12-16 | Buy |
Biosynth Carbosynth | FR159043 | Ramucirumab | 947687-13-0 | 25mg | $2150 | 2021-12-16 | Buy |
Ramucirumab Chemical Properties,Uses,Production
Clinical Use
Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal
cancer and non-small cell lung cancer (NSLC)
target
VEGFR2
Drug interactions
Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live
vaccines - avoid.
Metabolism
The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.
Ramucirumab Preparation Products And Raw materials
Raw materials
Preparation Products
Ramucirumab Suppliers
Global( 75)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hubei Ipure Biology Co., Ltd | +8613367258412 | ada@ipurechemical.com | China | 10326 | 58 |
HONG KONG IPURE BIOLOGY CO.,LIMITED | 86 18062405514 18062405514 | ada@ipurechemical.com | CHINA | 3465 | 58 |
Shanghai Minbiotech Co., Ltd. | +8617315815539 | sales@minbiotech.com | CHINA | 129 | 58 |
AFINE CHEMICALS LIMITED | +86-0571-85134551 | info@afinechem.com | China | 15394 | 58 |
Baoji Guokang Healthchem co.,ltd | +8615604608665 15604608665 | dominicguo@gk-bio.com | CHINA | 9427 | 58 |
BOC Sciences | 16314854226; +16314854226 | inquiry@bocsci.com | United States | 19743 | 58 |
Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 | shawn@hirisunpharm.com | CHINA | 9923 | 58 |
Wuhan Golt Biotech Co., Ltd. | +8615389281203 | maria@goltbiotech.com | China | 980 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
947687-13-0(Ramucirumab)Related Search:
Ramucirumab
Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
Cyramza
IMC-1121B
LY3009806
Ramucirumab (anti-VEGFR2)
947687-13-0